SLRX · Categories · Form 4

SLRX - SEC Form 4 insider transactions

Salarius Pharmaceuticals Inc. (SLRX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SLRX

• 157d
  Director Hanish Arnold C sold $17 worth of shares (27 units at $0.64), closing all direct ownership in the company (SEC Form 4)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 787d
  SEC Form 4 filed by Arthur David J.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 837d
  SEC Form 4 filed by Rosenblum Mark J

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 837d
  SEC Form 4 filed by Mcvicar William K.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 837d
  SEC Form 4 filed by Mccreedy Bruce J Jr.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 837d
  SEC Form 4 filed by Lieber Jonathan I

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 837d
  SEC Form 4 filed by Lammers Paul

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 837d
  SEC Form 4 filed by Burleson Tess

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 837d
  SEC Form 4 filed by Hanish Arnold C

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1209d
  SEC Form 4: Rosenblum Mark J was granted 6,432 shares, increasing direct ownership by 42% to 21,851 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1209d
  SEC Form 4: Arthur David J. was granted 14,300 shares, increasing direct ownership by 42% to 48,019 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1250d
  SEC Form 4: Lieber Jonathan I was granted 1,440 shares, increasing direct ownership by 96% to 2,940 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1250d
  SEC Form 4: Mccreedy Bruce J Jr. was granted 1,440 shares, increasing direct ownership by 414% to 1,788 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1250d
  SEC Form 4: Hanish Arnold C was granted 1,440 shares

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1250d
  SEC Form 4: Lammers Paul was granted 1,440 shares, increasing direct ownership by 518% to 1,718 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1250d
  SEC Form 4: Burleson Tess was granted 1,440 shares, increasing direct ownership by 112% to 2,722 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1250d
  SEC Form 4: Mcvicar William K. was granted 1,440 shares, increasing direct ownership by 414% to 1,788 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1250d
  SEC Form 4: Rosenblum Mark J was granted 8,000 shares, increasing direct ownership by 108% to 15,419 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1250d
  SEC Form 4: Arthur David J. was granted 20,000 shares, increasing direct ownership by 146% to 33,719 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1274d
  SEC Form 4: Arthur David J. was granted 2,693 shares, increasing direct ownership by 24% to 13,719 units (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1274d
  SEC Form 4: Rosenblum Mark J was granted 1,488 shares, increasing direct ownership by 25% to 7,419 units (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1308d
  SEC Form 4: Arthur David J. was granted 10,000 shares, increasing direct ownership by 91% to 21,026 units (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1308d
  SEC Form 4: Rosenblum Mark J was granted 7,314 shares, increasing direct ownership by 123% to 13,245 units (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1309d
  SEC Form 4: Arthur David J. was granted 10,000 shares, increasing direct ownership by 4% to 285,674 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1309d
  SEC Form 4: Rosenblum Mark J was granted 7,314 shares, increasing direct ownership by 5% to 155,633 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1462d
  SEC Form 4: Burleson Tess bought $4,986 worth of shares (27,700 units at $0.18), increasing direct ownership by 637% to 32,050 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1462d
  SEC Form 4: Lieber Jonathan I bought $7,016 worth of shares (37,500 units at $0.19)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1462d
  SEC Form 4: Mcvicar William K. bought $5,000 worth of shares (26,553 units at $0.19)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1463d
  SEC Form 4: Hanish Arnold C bought $5,152 worth of shares (28,000 units at $0.18)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1463d
  SEC Form 4: Hanish Arnold C bought $3,920 worth of shares (4,000 units at $0.98) (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1463d
  SEC Form 4: Hanish Arnold C bought $5,002 worth of shares (4,350 units at $1.15) (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1463d
  SEC Form 4: Hanish Arnold C bought $10,770 worth of shares (3,000 units at $3.59) (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1469d
  SEC Form 4: Arthur David J. bought $7,985 worth of shares (43,900 units at $0.18), increasing direct ownership by 8% to 281,674 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1469d
  SEC Form 4: Rosenblum Mark J bought $5,040 worth of shares (28,000 units at $0.18), increasing direct ownership by 23% to 148,319 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1495d
  SEC Form 4: Rosenblum Mark J was granted 10,000 shares, increasing direct ownership by 9% to 120,319 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1552d
  SEC Form 4: Rosenblum Mark J bought $29,812 worth of shares (76,246 units at $0.39), increasing direct ownership by 224% to 110,319 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1552d
  SEC Form 4: Arthur David J. bought $54,540 worth of shares (139,488 units at $0.39), increasing direct ownership by 127% to 249,674 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1599d
  SEC Form 4 filed by Mccreedy Bruce J Jr.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1599d
  SEC Form 4 filed by Lieber Jonathan I

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1599d
  SEC Form 4 filed by Mcvicar William K.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1599d
  SEC Form 4 filed by Arthur David J.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1599d
  SEC Form 4 filed by Burleson Tess

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1599d
  SEC Form 4 filed by Hanish Arnold C

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1599d
  SEC Form 4 filed by Lammers Paul

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1599d
  SEC Form 4 filed by Rosenblum Mark J

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1677d
  SEC Form 4: Arthur David J. was granted 7,939 shares, increasing direct ownership by 8% to 110,186 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1677d
  SEC Form 4: Rosenblum Mark J was granted 7,787 shares, increasing direct ownership by 30% to 34,073 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1756d
  SEC Form 4 filed by Salarius Pharmaceuticals, Inc.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1762d
  SEC Form 4 filed by Salarius Pharmaceuticals, Inc.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1860d
  SEC Form 4: Rosenblum Mark J was granted 9,563 units of Common Stock, increasing direct ownership by 57% to 26,286 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1860d
  SEC Form 4: Arthur David J. was granted 9,822 units of Common Stock, increasing direct ownership by 11% to 96,247 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

Other SLRX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends